Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice

European Journal of Immunology

Volumn 28, Issue 7, 1998, Pages 2066-2074

  Satoskar, Abhay R ^a   Okano, Mitsuhiro ^a   Connaughton, Suzanne ^b   Raisanen Sokolwski, Anne ^a   David, John R ^a   Labow, Mark ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HELPER CELL; IMMUNE DEFICIENCY; IMMUNIZATION; LEISHMANIA MAJOR; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SPLEEN CELL;

ANIMALS; FEMALE; HEMOCYANIN; INTERLEUKIN-4; LISTERIA INFECTIONS; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-1; TH2 CELLS;

EID: 0031824436     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X     Document Type: Article

References (51)

1. Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996. 87: 2095-2147.
2. Casey, L. C., Balk, R. A. and Bone, R. C., Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 1993. 119: 853-854.
3. Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Enders, S., Lonnemann, G., Corsetti, J., Chernow, B., Wilmore, D. W., Wolf, S. M. and Dinarello, C. A., Circulating interleukin-1 and tumor necrosis factor - in septic shock and experimental endotoxin fever. Crit. Care Med. 1992. 20: 1414-1419.
4. Eastgate, J. A., Symons, J. A., Wood, N. C., Grinlinton, F. M., di Giovine, F. S. and Duffy, D. S., Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988. ii: 706-709.
5. Vasilakos, J. P., Carroll, R. T., Emmerling, M. R., Doyle, P. D., Davis, R. E., Kim, K. S. and Shivers, B. D., Interleukine-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretion. FEBS Lett. 1994. 354: 289-292.
6. Kawano, M., Tanaka, H., Ishikawa, H., Nobuyoshi, M., Iwato, K., Asaoku, H., Tanabe, O. and Kuramoto, A., Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 1989. 73: 2145-2148.
7. Mori, N., Shirakawa, F., Murakami, S., Oda, S. and Eto, S., Interleukin-1α as an autocrine growth factor for acute lymphoblastic leukaemia cells. Br. J. Hematol. 1994. 86: 386-388.
8. Shirakawa, F., Tanaka, Y., Ota, T., Eto, S. and Yamashita, U., Autocrine stimulation of interleukin-1α in the growth of adult T cell leukemia. Cancer Res. 1989. 49: 1143-1147.
9. Bagby, G. C. J., Dinarello, C. A., Neerhout, R. C., Ridgway, D. and McCall, E., Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J. Clin. Invest. 1988. 82: 1430-1436.
10. Geiger, T., Towbin, H., Cosenti-Vargas, A., Zingel, O., Arnold, J., Rordorf, C., Glatt, M. and Vosbeck, K., Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acutephase response. Clin. Exp. Rheumatol. 1993. 11: 515-522.
11. Van Den Berg, W. B., Joosten, L. A. B., Helsen, M. and Van De Loo, F. A. J., Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 1994. 95: 237-243.
12. Ohlsson, K., Bjork, P., Bergenfeildt, M., Hageman, R. and Thompson, R. C., Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990. 348: 550-552.
13. Jacobs, C. A., Baker, P. E., Roux, E. R., Picha, K. S., Toivola, B., Waugh, S. and Kennedy, M. K., Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 1991. 146: 2983-2989.
14. Labow, M., Shuster, D., Zetterstrom, M., Nunes, P., Terry, R., Cullinan, E. B., Bartfai, T., Moldawer, L. L., Chizzonite, R. and McIntyre, K. W., Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor deficient mice. J. Immunol. 1997. 159: 2452-2461.
15. Sandberg, C. I., Imfeld, K. L., Zaldivar Jr., F., Wang, Z., Buckingham, B. A. and Berman, M. A., IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta. J. Immunol. 1995. 155: 5206-5212.
16. O'Garra, A. and Murphy, K., Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 1994. 6: 458-466.
17. Greenbaum, L. A., Horowitz, J. B., Woods, A., Pasqualini, T., Reich, E.-P. and Bottomly, K., Autocrine growth of CD4+ T cells. Differential effect of IL-1 on helper and inflammatory T cells. J. Immunol. 1988. 140: 1555-1560.
18. Lichtman, A. H., Chin, J., Schmidt, J. A. and Abbas, A. K., Role of interleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci. USA 1988. 85: 9699-9703.
19. Weaver, C. T., Hawrylowicz, C. M. and Unanue, E. R., T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 1988. 85: 8181-8185.
20. Ghezzi, P. and Dinarello, C. A., IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-γ. J. Immunol. 1988. 140: 4238-4244.
21. Vannier, E., Miller, L. C. and Dinarello, C. A., Coordinated anti-inflammatory effect of IL-4: IL-4 down regulates IL-1 synthesis but up regulates IL-1Ra production. Proc. Natl. Acad. Sci. USA 1992. 89: 4076-4078.
22. Sims, J. E., Gayle, M. A., Salck, J. L., Anderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Motovani, A., Shanebeck, K., Grabstein, K. H. and Dower, K. H., Interleukin-1 signalling occurs exclusively via type I receptor. Proc. Natl. Acad. Sci. USA 1993. 90: 6155-6159.
23. Sims, J. E., Giri, J. G. and Dower, S. K., The two interleukin-1 receptors play different roles in IL-1 activities. Clin. Immunol. Immunopathol. 1994. 72: 9-14.
24. Burch, R. M. and Mahan, L. C., Oligonucleotides antisense to the interleukin-1 receptor mRNA block the effects of interleukin-1 in cultured murine and human fibroblasts and in mice. J. Clin. Invest. 1991. 88: 1190-1196.
25. Schmitz, J., Assenmacher, M. and Radbruch, A., Regulation of T helper cell cytokine expression: functional dichotomy of antigen presenting cells. Eur. J. Immunol. 1993. 23: 191-199.
26. Scott, P., Natovitz, P., Coffman, R. L., Pearce, E. and Sher, A., Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 1988. 168: 1675-1684.
27. Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L. and Locksley, R. M., Reciprocal expression of interferon-gamma or interleukin-4 during resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 1989. 169: 59-72.
28. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 1991. 88: 7011-7015.
29. + subsets during murine Leishmania major infection. Res. Immunol. 1991. 142: 28-32.
30. Curry, A. J. and Kaye, P. M., Recombinant interleukin-1α augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani. Infect Immun. 1992. 60: 4422-4426.
31. Theodos, C. M., Shankar, A., Glasebrook, A. L., Roeder, W. D. and Titus, R. G., The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol. 1994. 16: 571-577.
32. Cillari, E., Dieli, M., Maltese, E., Milano, S., Salerno, A. and Liew, F. Y., Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-γ. J. Immunol. 1989. 143: 2001-2005.
33. Chakkalath, H. R. and Titus, R. G., Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 1994. 153: 4378-4387.
34. Hatzigeorgiou, D. H., He, S. H., Sobel, J., Hafner, A., Grabstein, K. H. and Ho, J. L., IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J. Immunol. 1993. 151: 3682-3692.
35. Guler, M. L., Gorham, J. D., Hsieh, C. S., Mackey, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M., Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996. 271: 984-988.
36. Hunter, C. A., Chizzonite, R. and Remington, J. S., IL-1 beta is required for IL-12 to induce production of IFN- gamma by NK cells. A role for IL-1 beta in the T cell-dependent mechanism of resistance against intracellular pathogens. J. Immunol. 1995. 155: 4347-4354.
37. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5326.
38. Shibuya, K., Robinson, D., Zonin, F., Hartley, S. B., Macatonia, S. E., Somozo, C., Hunter, C. A., Murphy, K. M. and O'Garra, A., IL-1α and TNF-α are required for IL-12 induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J. Immunol. 1998. 160: 1708-1716.
39. McKnight, A. J., Zimmer, G. J., Fogelman, I., Wolf, S. F. and Abbas, A. K., Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 1994. 152: 2172-2179.
40. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
41. Gajewski, T. F. and Fitch, F. W., Differential activation of murine Th1 and Th2 clones. Res. Immunol. 1991. 142: 19-23.
42. Paul, W. E. and Seder, R. A., Lymphocyte responses and cytokines. Cell 1994. 76: 241-245.
43. Howard, M., Mizel, S. B., Lachman, L., Ansel, J., Johnson, B. and Paul, W. E., Role of interleukin 1 in anti-immunoglobulin induced B cell proliferation. J. Exp. Med. 1983. 157: 1529-1535.
44. Reed, S. G., Phil, D. L., Conlon, P. J. and Grabstein, K. H., IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J. Immunol. 1989. 142: 3129-3133.
45. Reed, S. G., Phil, D. L. and Grabstein, K. H., Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production. J. Immunol. 1989. 142: 2067-2071.
46. Chizzolini, C., Chicheportiche, R., Burger, D. and Dayer, J.-M., Human Th1 cells preferentially induce interleukin (IL)-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur. J. Immunol. 1997. 27: 171-177.
47. Fenton, M. J., Buras, J. A. and Donnelly, R. P., IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 1992. 149: 1283-1288.
48. Orino, E., Sone, S., Nii, A. and Ogura, T., IL-4 up-regulates IL-1 receptor antagonist gene expression in human monocytes. J. Immunol. 1992. 149: 925-931.
49. Oriss, T. B., McCarthy, S. A., Morel, B. F., Campana, M. A. K. and Morel, P. A., Cross regulation between T helper cell (Th)1 and Th2. Inhibition of Th2 proliferation by IFN-γ involves interference with IL-1. J. Immunol. 1997. 158: 3666-3672.
50. Satoskar, A., Okano, M. and David, J. R., γδ T cells are not essential for control cutaneous Leishmania major infection in genetically resistant C57BL/6 mice. J. Infect. Dis. 1997. 176: 1649-1652.
51. Satoskar, A., Bluethamann H. and Alexander, J., Disruption of murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 1995. 63: 4894-4899.